The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
The company has entered into a long-term lease and operations and management agreement with Sree Chand Specialty Hospital, situated in Kannur
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US
The robotic surgery program has continually pushed the boundaries of medical technology
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
Revenue from Operations increased by 10.5% YoY to Rs. 7,567 crore with growth across the businesses
The pharma market is showing encouraging signs of improvement, positioning us well for future growth
Subscribe To Our Newsletter & Stay Updated
